Detection and duration of aspirin resistance after coronary artery bypass grafting.
Zimmermann
Norbert
N
Federal Institute for Drugs and Medical Devices, Bonn, Germany. nzimmermann@bfarm.de
Kurt
Muhammed
M
Winter
Joachim
J
Gams
Emmeran
E
Wenzel
Folker
F
Hohlfeld
Thomas
T
D001241:Aspirin / Q000009:adverse effects*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D004351:Drug Resistance; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin